Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

NEXGARD SPECTRA - Health Canada Drug Approval Details

Approvals/Health Canada/NEXGARD SPECTRA

Authorized

STANDARD

NEXGARD SPECTRA

BOEHRINGER INGELHEIM ANIMAL HEALTH CANADA INC.🇨🇦 Health Canada

Approval Date: Apr 6, 2026
Approval ID: 2348201fa41ac47f
Company: BOEHRINGER INGELHEIM ANIMAL HEALTH CANADA INC.
Type: Standard

Approval Details

Approval Id: 2348201fa41ac47f
Drug Approval Canada Name: NEXGARD SPECTRA
Product Name: NEXGARD SPECTRA
Status: Marketed
Status Date: 2019-07-22
Original Market Date: 2019-01-07
Drug Class: Veterinary
Dosage Form: Tablet (Chewable)
Route Of Administration: Oral
Schedule: PRESCRIPTION
Atc Original: Not Applicable
Aig Number: 0259990005
Company Name: BOEHRINGER INGELHEIM ANIMAL HEALTH CANADA INC.
Company Address: 5180 South Service Road Burlingtion Ontario Canada L7L 5H4

Authorized

Quick Info

Agency

Health Canada

Country

🇨🇦

Approval Date

Apr 6, 2026

Approval ID

2348201fa41ac47f

Type

Standard

Back to Health Canada Approvals